Literature DB >> 28301369

"Should Patients With Substance Use Disorders Be Prescribed Benzodiazepines?" No.

Robert L DuPont1.   

Abstract

Patients with substance use disorders (SUDs) should not use benzodiazepines to treat anxiety, insomnia, or anything else, for the same reasons that they should not drink any alcohol or use other drugs, regardless of their primary drug used. Once the addiction "switch" is thrown on, it never again goes off. This question has additional relevance today because in 2016, the US Food and Drug Administration put black box warnings on all benzodiazepines and opioid analgesics about the serious risks associated with their concomitant use. Anxiety is not a benzodiazepine-deficiency disease. It is possible to treat anxiety and insomnia without medicines of any kind, and it is possible to use medicines other than benzodiazepines for these common and serious mental disorders. Although many patients with SUDs are eager to use benzodiazepines, using alternatives is often effective and it does not put the patient's recovery in jeopardy. The standard I propose here is based on the experience of many people with SUDs who have tried and failed to use benzodiazepines for anxiety.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28301369     DOI: 10.1097/ADM.0000000000000291

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  4 in total

1.  Benzodiazepine misuse in adults with alcohol use disorder: Prevalence, motives and patterns of use.

Authors:  R Kathryn McHugh; Victoria R Votaw; Nadine R Taghian; Margaret L Griffin; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2020-06-22

2.  Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.

Authors:  Gerald Cochran; Wei-Hsuan Lo-Ciganic; Walid F Gellad; Adam J Gordon; Evan Cole; Carroline Lobo; Winfred Frazier; Ping Zheng; Chung-Chou H Chang; David Kelley; Julie M Donohue
Journal:  J Manag Care Spec Pharm       Date:  2018-09

3.  Abuse Liability of Baclofen.

Authors:  Samir Kumar Praharaj
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-02-28       Impact factor: 2.582

4.  Sleep Disorder in Drug Addiction: Treatment With Transcranial Magnetic Stimulation.

Authors:  Xiangju Du; Weiqian Xu; Xingxing Li; Dongsheng Zhou; Cuilan Han
Journal:  Front Psychiatry       Date:  2019-11-19       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.